194 related articles for article (PubMed ID: 24332713)
1. [KIR-HLA class i and pulmonary tuberculosis in the Amerindian population in Chaco, Argentina].
Habegger de Sorrentino A; Pardo R; Marinic K; Duarte SC; Lotero C
Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):565-9. PubMed ID: 24332713
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin like receptor gene association with tuberculosis.
Pydi SS; Sunder SR; Venkatasubramanian S; Kovvali S; Jonnalagada S; Valluri VL
Hum Immunol; 2013 Jan; 74(1):85-92. PubMed ID: 23073291
[TBL] [Abstract][Full Text] [Related]
4. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
5. Activating KIRs alter susceptibility to pulmonary tuberculosis in a South African population.
Salie M; Daya M; Möller M; Hoal EG
Tuberculosis (Edinb); 2015 Dec; 95(6):817-821. PubMed ID: 26542219
[TBL] [Abstract][Full Text] [Related]
6. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
[TBL] [Abstract][Full Text] [Related]
7. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
[TBL] [Abstract][Full Text] [Related]
8. Potential implication of activating killer cell immunoglobulin-like receptor and HLA in onset of pulmonary tuberculosis.
Lu C; Bai XL; Shen YJ; Deng YF; Wang CY; Fan G; Chu JX; Zhao SM; Zhang BC; Zhao YR; Zhang CZ; Ye H; Lu ZM
Scand J Immunol; 2012 Nov; 76(5):491-6. PubMed ID: 22862677
[TBL] [Abstract][Full Text] [Related]
9. Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian First Nations cohort.
Braun K; Larcombe L; Orr P; Nickerson P; Wolfe J; Sharma M
PLoS One; 2013; 8(7):e67842. PubMed ID: 23861818
[TBL] [Abstract][Full Text] [Related]
10. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.
Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M
Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
[TBL] [Abstract][Full Text] [Related]
12. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
13. Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.
Garrido-Rodríguez D; Ávila-Ríos S; García-Morales C; Valenzuela-Ponce H; Ormsby C; Reyes-Gopar H; Fernandez-Lopez JC; Reyes-Terán G
Immunogenetics; 2016 Oct; 68(9):703-17. PubMed ID: 27240860
[TBL] [Abstract][Full Text] [Related]
14. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.
Gendzekhadze K; Norman PJ; Abi-Rached L; Graef T; Moesta AK; Layrisse Z; Parham P
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18692-7. PubMed ID: 19837691
[TBL] [Abstract][Full Text] [Related]
15. KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.
Flores AC; Marcos CY; Paladino N; Capucchio M; Theiler G; Arruvito L; Pardo R; Habegger A; Williams F; Middleton D; Fainboim L
Tissue Antigens; 2007 Jun; 69(6):568-76. PubMed ID: 17498266
[TBL] [Abstract][Full Text] [Related]
16. Association of KIR3DS1+HLA-B Bw4Ile80 combination with susceptibility to tuberculosis in Lur population of Iran.
Shahsavar F; Mousavi T; Azargon A; Entezami K
Iran J Immunol; 2012 Mar; 9(1):39-47. PubMed ID: 22426166
[TBL] [Abstract][Full Text] [Related]
17. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
[TBL] [Abstract][Full Text] [Related]
18. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
19. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
